Sandra Patterson

A unique $4M award program aims to solve a critical funding gap, accelerating high-risk, high-reward cancer therapies from academic labs to patients.

A new agreement could see South Korea's INNOSPACE launch from Canada, positioning Spaceport Nova Scotia as a key player in the global space race.

Esperion's $75M+ deal for Corstasis and its novel nasal diuretic, Enbumyst, targets a $4B market and a new era of at-home edema management.

NRG Energy's stock tumbles after it orchestrates a major share sale for a key investor alongside a strategic $300 million buyback, a complex move.

Zymeworks lands $250M from Royalty Pharma in a non-dilutive deal, validating its cancer drug Ziihera and highlighting a new era of biotech financing.

With 19M+ views and a $120M valuation, an AI-powered startup is connecting home cooks with diners, challenging the 300-year-old restaurant model.

Oportun celebrates a major financial turnaround and its fifth straight profitable quarter, but a closer look reveals rising delinquencies and new headwinds.

BLUETTI's new Elite 300 packs 3kWh of power into a surprisingly small frame, aiming to be the go-to for storm prep and off-grid travel.

A new report reveals record renewable growth is causing grid saturation and price volatility, pushing AI and battery storage to the forefront of the solution.

A landmark partnership between US entrepreneurs and a top Kenyan university aims to equip a new generation to own and scale Africa's booming creative sector.

A key partnership ensures the supply of a breakthrough therapy for FOP, a devastating condition where muscle turns to bone, highlighting a new era in drug production.

The energy giant unveils a massive capital plan to boost regulated assets, even as a $471M write-down on renewables reveals significant grid challenges.

Techem's new sustainability report reveals an 11.2% CO2e drop, a major digital rollout with 85% smart devices, and new e-mobility and circular economy goals.

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

As Tennessee's hospitality sector booms, one company is integrating kitchen design and equipment supply to help restaurants open faster than ever.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

Silfab Solar appoints financial veteran Phung Ngo-Burns as CFO, a strategic move to navigate its major U.S. expansion amid a booming domestic solar market.

As autonomous agents and shadow AI run rampant, Symmetry's new platform offers unified visibility and control to prevent data loss and compliance chaos.

In a strategic push into critical infrastructure, GCG's latest acquisition of a family-owned cable specialist signals a major play for the data center market.

A landmark partnership aims to bring precision cancer therapy, or Theranostics, to millions in underserved nations, backed by a major WHO resolution.